NCT02626949

Brief Summary

By 2015 half of the people living with HIV infection in the U.S. are estimated be over the age of 50, and this cohort of patients with well-controlled plasma viremia is aging at a more rapid pace than their non-HIV peers. Long-term chronic inflammation plays a critical role in premature aging in HIV-infected adults. Markers associated with chronic inflammation, including IL-6, CRP, sCD14 and d-dimer, have not only been shown to be present at higher levels in HIV-infected adults, but are also correlated to a wide variety of morbidities and mortality. The goal of this project is to determine the impact of two different interventions -- Mindfulness-Based Stress Reduction (MBSR) and Health Enhancement Program (HEP) -- on reducing biological markers associated with chronic inflammation in HIV-infected adults with an undetectable HIV viral load. In order to achieve this goal, a pilot RCT with 120 subjects over 50 years old who are on anti-retroviral therapy (ART) will be conducted with the following specific aims: 1) to assess the effect of MBSR and/or HEP on biomarkers of chronic inflammation (IL-6, CRP, sCD14, d-dimer), and, 2) to explore whether changes in psychological well-being (anxiety, depression, fatigue, cognitive functioning) mediate the impact on chronic inflammation. Subjects will be randomized to participation in a group MBSR course or to the HEP group both of which consist of 8 weekly sessions followed by 6 monthly booster sessions. Three time points will be measured: baseline, 8 weeks (immediately after completion of weekly intervention), and 6-months post-completion of weekly intervention. Mixed linear and structural equation model will be used to test the study hypotheses. The proposed study is innovative in that it is the first to explore the impact of a complementary mind-body intervention on chronic inflammation in HIV-infected adults. Given that the consequences of early aging in this cohort will be a burden on the health care system as well as a medical, social and psychological burden on those living with HIV, the study has the potential to have a major public health impact.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 10, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2017

Completed
4.4 years until next milestone

Results Posted

Study results publicly available

May 9, 2022

Completed
Last Updated

May 9, 2022

Status Verified

April 1, 2022

Enrollment Period

1.8 years

First QC Date

December 8, 2015

Results QC Date

March 15, 2022

Last Update Submit

April 11, 2022

Conditions

Keywords

HIVAIDSMindfulnessMindfulness-based stress reductionStressInterventionInflammation

Outcome Measures

Primary Outcomes (1)

  • Interleukin 6 (IL-6) Biological Markers

    Interleukin 6 (IL-6) biological markers at 8 weeks and 6 months as compared to baseline.

    Baseline, 8 weeks post intervention, and 6 months post intervention

Secondary Outcomes (5)

  • PROMIS - Anxiety

    Baseline, 8 weeks post intervention, and 6 months post intervention

  • PROMIS - Fatigue

    Baseline, 8 weeks post intervention, and 6 months post intervention

  • BDI-II

    Baseline, 8 weeks post intervention, and 6 months post intervention

  • FFMQ

    Baseline, 8 weeks post intervention, and 6 months post intervention

  • Retention Rates

    6 months

Study Arms (2)

MBSR Course

EXPERIMENTAL

Mindfulness-Based Stress Reduction Course (MBSR) consisting of 8 weekly sessions, 2.5 hours each, and a 5 hour silent retreat during the 6th week of the program.

Behavioral: MBSR Course

HEP Course

EXPERIMENTAL

Health Enhancement Program (HEP) consisting of 8 weekly sessions, 2.5 hours each, and 1.5 hour monthly educational sessions after the 8 week intervention.

Behavioral: HEP Course

Interventions

MBSR CourseBEHAVIORAL

Formal mindfulness meditation methods taught in the MBSR course include: Body Scan Meditation (a supine meditation), Gentle Hatha Yoga (practiced with mindful awareness of the body), Sitting Meditation (mindfulness of breath, body, feelings, thoughts, and emotions), and Walking Meditation. Informal Mindfulness Meditation Practices (mindfulness in everyday life) include: 1) awareness of pleasant and unpleasant events, and, 2) deliberate awareness of routine activities and events such as eating, weather, walking, and interpersonal communication. Daily home assignments include a minimum of 30 minutes daily formal mindfulness practices and 5-15 minutes informal practice, 6 days per week for the entire duration of the course. Course sessions will consist of discussions oriented around weekly homework assignments, including an exploration of obstacles, and development of self-regulatory skills and capacities.

Also known as: Mindfulness meditation, Mindfulness-Based Stress Reduction
MBSR Course
HEP CourseBEHAVIORAL

HEP is an active control that matches MBSR in non-specific factors, such as the amount of time participants interact, but does not include mindfulness practice as an active component. HEP instructors will be selected from experts in the areas covered: music, nutrition education, and, functional movement. The study's RC will coordinate HEP sessions and monitor attendance. Following the 8-week HEP protocol, subjects will meet monthly in 1.5-hour educational sessions to match the booster sessions of MBSR participants.

Also known as: Health Enhancement Program
HEP Course

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-infected for 5 or more years
  • On ART for 5 or more years
  • HIV viral load consistently \<48 copies/mL for the last year
  • No anticipated changes in ART by provider or patient
  • Fluency in the English language
  • Age 45 years or older
  • Willingness to complete the entire MBSR or HEP interventions

You may not qualify if:

  • Having participated in an MBSR course in the past
  • Current meditation and/or yoga practice
  • Began psychiatric medications in the past 2 months or plans to discontinue psychiatric medications
  • Currently receiving steroids or immunosuppressant drugs
  • Women who are pregnant or plan to become pregnant in the next year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeInflammation

Interventions

MindfulnessMindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Jeffrey Weiss, PhD, MS
Organization
Icahn School of Medicine at Mount Sinai

Study Officials

  • Jeffrey Weiss, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR
  • Peter Barbosa, PhD

    New York College of Podiatric Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 10, 2015

Study Start

March 1, 2016

Primary Completion

December 18, 2017

Study Completion

December 18, 2017

Last Updated

May 9, 2022

Results First Posted

May 9, 2022

Record last verified: 2022-04

Locations